Skip to main content
. Author manuscript; available in PMC: 2008 Jun 1.
Published in final edited form as: Neurobiol Dis. 2007 Mar 24;26(3):688–695. doi: 10.1016/j.nbd.2007.03.006

Figure 2.

Figure 2

Comparison of HO-1 expression after treatment with Ad-GFAP-HO-1 or Ad-CMV-HO-1. HO-1 knockout astrocyte cultures were treated with 0, 10, or 100 MOI Ad-Null, Ad-CMV-HO-1, or Ad-GFAP-HO-1 for 24 hours. Additional cultures that were treated with Ad-GFAP-HO-1 were also treated with 1 mM dibutyryl cAMP (dbcAMP) to increase GFAP promoter activity.